A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

Tuszynski, Mark H, Thal, Leon, Pay, Mary, Salmon, David P, U, Hoi Sang, Bakay, Roy, Patel, Piyush, Blesch, Armin +10 more·2005·Nature Medicine
DOI 10.1038/nm1239

Cited by (1,001)

Items 601–700 of 1,001

  1. From the Multifactorial Nature of Alzheimer`s Disease to Multitarget Therapy: The Contribution of the Translational Approach
    Laura Calzà, Vito Antonio Baldassarro, Alessandro Giuliani, Luca Lorenzini, Mercedes Fernández, Chiara Mangano, Sandra Sivilia, Marco Alessandri, Marco Gusciglio, Roberta Torricella et al. · 2013 · Current Topics in Medicinal Chemistry
  2. The Harm-Benefit Tradeoff in “Bad Deal” Trials
    Gillian Nycum, L. Reid · 2008 · Kennedy Institute of Ethics Journal
  3. Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases
    Shripriya Singh, Akriti Srivastava, Pranay Srivastava, Yogesh Kumar Dhuriya, Ankita Pandey, Dipak Kumar, Chetan Singh Rajpurohit · 2016 · Frontiers in Molecular Biosciences
  4. Validation of a Novel Telehealth Administration Protocol for the NIH Toolbox-Cognition Battery
    Alexander D. Rebchuk, Halina M. Deptuck, Zoe Rose O'Neill, DS Fawcett, Noah D. Silverberg, Thalia S. Field · 2018 · Telemedicine Journal and e-Health
  5. Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease
    Lucie Cahlíková, Kateřina Macáková, Nina Benešová, Jakub Chlebek, Anna Hošťálková, Lubomı́r Opletal · 2014 · Studies in natural products chemistry
  6. Nerve Growth Factor Differentially Affects Spatial and Recognition Memory in Aged Rats
    Grażyna Niewiadomska, Marta Baksalerska-Pazera, Anna Gąsiorowska, Anna Mietelska‐Porowska · 2006 · Neurochemical Research
  7. Basic Principles of Peripheral Nerve Disorders
    Seyed Mansoor Rayegani · 2012 · InTech eBooks
  8. Nerve growth factor in brain diseases
    Stefania Ciafrè, Valentina Carito, Giampiero Ferraguti, Antonio Greco, Massimo Ralli, Paola Tirassa, George N. Chaldakov, Marisa Patrizia Messina, Maria Luisa Attilia, Rosaria Ceccarelli et al. · 2018 · Biomedical Reviews
  9. Emerging Gene Therapies for Alzheimer’s and Parkinson’s Diseases: An Overview of Clinical Trials and Promising Candidates
    Will S Roberts, Shawn Price, Michael Wu, Mayur S. Parmar · 2024 · Cureus
  10. Chapter 55 Neural transplantation
    Stephen B. Dunnett · 2009 · Handbook of clinical neurology
  11. Gene transfer mediated by stem cell grafts to treat CNS injury
    Dong Hoon Hwang, Soo Ryeong Jeong, Byung Gon Kim · 2011 · Expert Opinion on Biological Therapy
  12. Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization
    Cinzia Severini, Pamela Petrocchi Passeri, Maria Teresa Ciotti, Fulvio Florenzano, Carla Petrella, Francesca Malerba, B. Bruni, Mara D’Onofrio, Ivan Arisi, Rossella Brandi et al. · 2017 · Neuropharmacology
  13. Cell-based therapy in Alzheimer's disease: can human fetal cholinergic neurons “untangle the skein”?
    Giulia Guarnieri, Erica Sarchielli, Gabriella B. Vannelli, Annamaria Morelli · 2018 · Neural Regeneration Research
  14. Translational Potential of Rats in Research
    Sara A. Hashway, Laura A. Wilding · 2019 · Elsevier eBooks
  15. Viral vectors as a promising nanotherapeutic approach against neurodegenerative disorders
    Vaibhavi Srivastava, Ajit Singh, Gaurav Kumar Jain, Farhan Jalees Ahmad, Rahul Shukla, Prashant Kesharwani · 2021 · Process Biochemistry
  16. A novel inducible tyrosine kinase receptor to regulate signal transduction and neurite outgrowth
    Ronald W. Alfa, Mark H. Tuszynski, Armin Blesch · 2009 · Journal of Neuroscience Research
  17. Central Nervous System
    Tobias Führmann, José Gerardo‐Nava, Gary Anthony Brook · 2010 · Springer eBooks
  18. Gene Therapy of Focal-Onset Epilepsy Using Adeno-Associated Virus Vector-Mediated Overexpression of Neuropeptide Y
    Francesco M. Noè, Andreas Toft Sørensen, Mérab Kokaia, Annamaria Vezzani · 2012 · Oxford University Press eBooks
  19. Analysis of Gene Expression and Neuronal Phenotype in Neuroscreen-1 (NS-1) Cells
    Gordon C. Ibeanu · 2018 · International Journal of Biomedical Investigation
  20. Gene transfer therapy for neurodegenerative disorders
    Andrew Feigin, David Eidelberg · 2007 · Movement Disorders
  21. Neurotrophin Signaling and Cell Survival
    Bruno J. Manadas, Carlos V. Melo, João R. Gomes, Carlos Bandeira Duarte · 2007 · Springer eBooks
  22. NGF receptor TrkAd5: therapeutic agent and drug design target
    D. Dawbarn, M. Fahey, Judy J. Watson, SJ Tyler, Deborah K. Shoemark, Richard Barry Sessions, R. Zhang, Leo Brady, Christine L. Willis, Shelley Jane Allen · 2006 · Biochemical Society Transactions
  23. Fusion–fission–mitophagy cycling and metabolic reprogramming coordinate nerve growth factor ( NGF )‐dependent neuronal differentiation
    Ilaria Goglia, Ewelina Węglarz‐Tomczak, C. Gioia, Yanhua Liu, Assunta Virtuoso, Marcella Bonanomi, Daniela Gaglio, Noemi Salmistraro, Ciro De Luca, Michele Papa et al. · 2024 · FEBS Journal
  24. Multimodal beneficial effects of BNN27, a nerve growth factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s disease
    Maria Kokkali, K. Karali, Evangelia Thanou, M. Papadopoulou, Ioanna Zota, Alexandros Tsimpolis, P. Efstathopoulos, T. Calogeropoulou, Ka-Wan Li, Kyriaki Sidiropoulou et al. · 2024 · Molecular Psychiatry
  25. Neurotrophic factor alpha 1 gene therapy in Alzheimer’s disease: scope and advancements
    Ammara Shaikh, Fairus Ahmad, Seong Lin Teoh, Jaya Kumar, Mohamad Fairuz Yahaya · 2025 · Frontiers in Molecular Neuroscience
  26. Pro-neurogenesis and anti-dementia properties of tetradecyl 2,3-dihydroxybenzoate through TrkA receptor-mediated signalling pathways
    Libin Zhou, Zihong Lu, Lin Li, Lei Chen, Jianhua Qi, Ling Chen · 2014 · The International Journal of Neuropsychopharmacology
  27. aFGF Promotes Neurite Growth by Regulating GSK3β-CRMP2 Signaling Pathway in Cortical Neurons Damaged by Amyloid-β
    Qin Cun Cao, Tian Meng, Jianhui Man, Dong Peng, Hongxia Chen, Qi Xiang, Zhijian Su, Qihao Zhang, Yadong Huang · 2019 · Journal of Alzheimer s Disease
  28. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Ling‐Yun Fan, Ming‐Jang Chiu · 2010 · PubMed
  29. Therapeutic technology
    Michael E. Selzer, Stéphanie Clarke, Leonardo G. Cohen, Gert Kwakkel, Robert H. Miller · 2014 · Cambridge University Press eBooks
  30. Gene- and Cell-Based Approaches for Neurodegenerative Disease
    Klaudia Urbaniak Hunter, Chester K. Yarbrough, Joseph D. Ciacci · 2010 · Advances in experimental medicine and biology
  31. Transfection of Mammalian Cells Using Block Copolypeptide Vesicles
    Victor Z. Sun, Uh‐Joo Choe, April R. Rodriguez, Howard Dai, Timothy J. Deming, Daniel T. Kamei · 2013 · Macromolecular Bioscience
  32. Retinoic acid and nerve growth factor induce differential regulation of nicotinic acetylcholine receptor subunit expression in SN56 cells
    Mats Nilbratt, Linda Friberg, Malahat T. Mousavi, Amelia Marutle, Agneta K. Nordberg · 2007 · Journal of Neuroscience Research
  33. Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9
    Aletta C. Schnitzler, Ignacio López G.‐Coviella, Jan Krzysztof Blusztajn · 2008 · Brain Research
  34. Drug Treatments in Development for Alzheimer's Disease
    Michael C. Woodward · 2012 · Journal of Pharmacy Practice and Research
  35. Nerve growth factor and autophagy: effect of nasal anti-NGF-antibodies administration on Ambra1 and Beclin-1 expression in rat brain
    Pamela Rosso, Sandra Moreno, Anna Fracassi, Maria Luisa Rocco, Luigi Aloe · 2015 · Growth Factors
  36. Monitoring maturation of neural stem cell grafts within a host microenvironment
    Olga Kopach · 2019 · World Journal of Stem Cells
  37. CNS Gene Therapy and a Nexus of Complexity: Systems and Biology at a Crossroads
    Carolyn M. Tyler, Howard J. Federoff · 2006 · Cell Transplantation
  38. Growth Factor Gene Therapy for Alzheimer’s Disease
    Mark H. Tuszynski · 2024 · Journal of Alzheimer s Disease
  39. Molecular target discovery for neural repair in the functional genomics era
    Joost Verhaagen, Ronald E. van Kesteren, Koen Bossers, Harold D. MacGillavry, Matthew R. J. Mason, August Benjamin Smit · 2012 · Handbook of clinical neurology
  40. Alzheimer′s disease: The role for neurosurgery
    Julio LeonardoBarbosa Pereira, Alessandra Augusta Gorgulho, Vishal Nainesh Patel, Dennis R. Malkasian, Antônio De Salles, Angela E. Downes · 2014 · Surgical Neurology International
  41. Growth Factors
    Wilma Friedman · 2012 · Elsevier eBooks
  42. Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease
    Lauren Owens, Alexandre Benedetto, Neil Dawson, Christopher J. Gaffney, Edward T. Parkin · 2021 · Brain Research
  43. Effects of far infrared light on Alzheimer’s disease-transgenic mice
    Koji Fukui, Kimura Shunsuke, Yugo Kato, Masahiro Kohno · 2021 · PLoS ONE
  44. FDG PET in dementia multicenter studies and clinical trials
    Karl Herholz, Henning Boecker, Imola Németh, Graham Dunn · 2013 · Clinical and Translational Imaging
  45. NEUROTROPHIC FACTORS
    Eugene M. Johnson, Mark H. Tuszynski · 2008 · Elsevier eBooks
  46. The delicate balance between neurotoxicity and neuroprotection in the context of HIV ‐1 infection
    Vincent Sénécal, Corinne Barat, Michel J. Tremblay · 2020 · Glia
  47. Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity
    Carla Petrella, Maria Teresa Ciotti, Robert Nisticò, Sonia Piccinin, Pietro Calissano, Simona Capsoni, Delio Mercanti, Sebastiano Cavallaro, Roberta Possenti, Cinzia Severini · 2020 · Cells
  48. Adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases
    Masayuki Kuroda, Hideaki Bujo, Masayuki Aso, Yasushi Saitō · 2011 · Journal of Diabetes Investigation
  49. Comparison of AAV Serotypes for Gene Delivery to Dopaminergic Neurons in the Substantia Nigra
    Joanna A. Korecka, Marijn Schouten, Ruben Eggers, Ayşe Ulusoy, Koen Bossers, Joost Verhaage · 2011 · InTech eBooks
  50. Neurotrophins - More than Neurotrophic
    Shamini Ayyadhury, Klaus Heese · 2007 · Current Immunology Reviews
  51. Pharmacological Treatment of Alzheimer`s Disease: Is it Progressing Adequately?
    Alfredo Robles · 2009 · The Open Neurology Journal
  52. Receptor Targets in Alzheimer’s Disease Drug Discovery
    Jason V. Wallach, Tristan Colestock, Adeboye Adejare · 2016 · Elsevier eBooks
  53. Multicompartment Lipid Nanocarriers for Targeting of Cells Expressing Brain Receptors
    Claire Géral, Angelina Angelova, Borislav Angelov, Valérie Nicolas, Sylviane Lesieur · 2012
  54. Opportunities in rehabilitation research
    Alexander K. Ommaya, Kenneth M. Adams, Richard M. Allman, Eileen G. Collins, Rory A. Cooper, C. Edward Dixon, Paul S. Fishman, James A. Henry, Randy H. Kardon, Robert D. Kerns et al. · 2013 · The Journal of Rehabilitation Research and Development
  55. Adult Neurogenesis in Neurodegenerative Diseases
    Tomas Deierborg, Jiayi Li, Patrik Brundin · 2007 · Springer eBooks
  56. Time-Dependent Activation of c-fos in Limbic Brain Areas by Ocular Administration of Nerve Growth Factor in Adult Rats
    Arianna Calza, Fulvio Florenzano, Daniela Pellegrini, Paola Tirassa · 2011 · Journal of Ocular Pharmacology and Therapeutics
  57. NGF protects corneal, retinal, and cutaneous tissues/cells from phototoxic effect of UV exposure
    Maria Luisa Rocco, Bijorn Omar Balzamino, Luigi Aloe, Alessandra Micera · 2018 · Graefe s Archive for Clinical and Experimental Ophthalmology
  58. Fast Alpha Activity in EEG of Patients With Alzheimer’s Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor
    Helga Eyjolfsdottir, Thomas W. Koenig, Azadeh Karami, Per M. Almqvist, Göran Lind, Bengt Linderoth, Lars U. Wahlberg, Åke Seiger, Taher Darreh‐Shori, Maria Eriksdotter et al. · 2022 · Frontiers in Aging Neuroscience
  59. Stem cell transplantation for enhancement of learning and memory in adult neurocognitive disorders.
    Ben Waldau · 2010 · Europe PMC (PubMed Central)
  60. Stimulation of choline acetyltransferase by C3d, a neural cell adhesion molecule ligand
    Alison Burgess, Saumya Saini, Yingqi Weng, Isabelle Aubert · 2008 · Journal of Neuroscience Research
  61. Association between Nerve Growth Factor Gene Polymorphism and Executive Dysfunction in Japanese Patients with Early-Stage Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
    Tomoyuki Nagata, Shunichiro Shinagawa, Kazutaka Nukariya, Ritsuko Nakayama, Kazuhiko Nakayama, Hisashi Yamada · 2011 · Dementia and Geriatric Cognitive Disorders
  62. Bacteria-induced static batch fungal fermentation of the diterpenoid cyathin A3, a small-molecule inducer of nerve growth factor
    Emma Dixon, Tatiana Schweibenz, Alison Hight, Brian Kang, Allyson Dailey, Sarah Kim, Meng-Yang Chen, Yura Kim, Sarah Neale, Ashley Groth et al. · 2010 · Journal of Industrial Microbiology & Biotechnology
  63. Age-related changes of NGF, BDNF, parvalbumin and neuronal nitric oxide synthase immunoreactivity in the mouse hippocampal CA1 sector
    Natsumi Hayakawa, Manami Abe, Risa Eto, Hiroyuki Kato, Tsutomu Araki · 2008 · Metabolic Brain Disease
  64. Nonviral Gene Delivery in Neural Progenitors Derived from Human Pluripotent Stem Cells
    Sujoy Kumar Dhara, Anirban Majumder, Mahesh Chandra Dodla, Steven L. Stice · 2011 · Methods in molecular biology
  65. Nanotechnology in gene delivery for neural regenerative medicine
    Mona Shahlaei, Shaahin Mohammadzadeh Asl, Maryam Saeidifar · 2020 · Elsevier eBooks
  66. Gene Therapy for Alzheimer and Parkinson Diseases
    Jasen F. Saad, Fawzy Ali Saad · 2023 · Current Gene Therapy
  67. Challenges in advancing Schwann cell transplantation for spinal cord injury repair
    James David Guest, Andrea J. Santamaría, Juan Pablo Solano, Juan Pablo de Rivero Vaccari, William D. Dietrich, Damien Daniel Pearse, Aisha Khan, Allan D. Levi · 2024 · Cytotherapy
  68. New BDNF and NT-3 Cyclic Mimetics Concur with Copper to Activate Trophic Signaling Pathways as Potential Molecular Entities to Protect Old Brains from Neurodegeneration
    Antonio L. Magrì, Barbara Tomasello, Налетова Ирина Николаевна, Giovanni Tabbı̀, Warren R. L. Cairns, Valentina Greco, Sebastiano Sciuto, Diego La Mendola, Enrico Rizzarelli · 2024 · Biomolecules
  69. Advances and Challenges in Gene Therapy for Alzheimer’s Disease
    Fabiana Morroni, Antonella Caccamo · 2024 · Journal of Alzheimer s Disease
  70. Molecular pathogenesis, experimental therapy and genetic counseling in hereditary sensory neuropathies
    Magdalena Mroczek, Dagmara Kabzińska, Andrzej Kochański · 2015 · Acta Neurobiologiae Experimentalis
  71. Cortical Plasticity in Response to Injury and Disease
    Nina Weishaupt · 2017 · Elsevier eBooks
  72. Gene Therapy Strategies: Gene Augmentation
    Clévio Nóbrega, Liliana S. Mendonça, Carlos A. Matos · 2020 · Springer eBooks
  73. Multifunctional Polymeric Nano-Carriers in Targeted Drug Delivery
    Ashish Kumar Agrawal, Dileep Urimi, Sanyog Jain · 2014 · Advances in delivery science and technology
  74. Neuroprotection and Enhancement of Neurite Outgrowth With Small Molecular Weight Compounds From Screens of Chemical Libraries
    Donard S. Dwyer, Addie Dickson · 2006 · International review of neurobiology
  75. β/A4‐Amyloid increases nerve growth factor production in rat primary hippocampal astrocyte cultures
    Olaf Schulte‐Herbrüggen, Ulrike Hamker, Volker Meske, Heidi Danker‐Hopfe, Thomas Georg Ohm, Rainer Hellweg · 2007 · International Journal of Developmental Neuroscience
  76. Eyes on the prize: Federal Alzheimer's research effort aims to facilitate interventions
    Richard J. Hodes, Neil S. Buckholtz, Vicky Cahan, Marcelle Morrison‐Bogorad · 2007 · Alzheimer s & Dementia
  77. The proline-rich hypothalamic peptide is a modulator of functions of neurotrophins and neuronal activity in amyloid-induced neurodegeneration
    M. I. Aghajanov, Konstantin B. Yenkoyan, Vergine A. Chavushyan, John S. Sarkissian · 2014 · Neurochemical Journal
  78. The role of chalcones: helichrysetin, xanthohumol, and flavokawin-C in promoting neurite outgrowth in PC12 Adh cells
    Chia‐Wei Phan, Vikineswary Sabaratnam, Wai-Kuan Yong, Sri Nurestri Abd Malek · 2017 · Natural Product Research
  79. Treatment of dementia: anything new?
    João Carlos Machado, Paulo Caramelli · 2006 · Current Opinion in Psychiatry
  80. Commentary on “Challenges to demonstrating disease‐modifying effects in Alzheimer's disease clinical trials”
    Paul S. S. Aisen · 2006 · Alzheimer s & Dementia
  81. Current and future therapeutic approaches in progressive supranuclear palsy
    Irene van Balken, Irene Litvan · 2008 · Handbook of clinical neurology
  82. Identification and early characterization of genetically modified NGF-producing neural stem cells grafted into the injured adult rat brain
    Lucia Pagani, Carlo Cenciarelli, Patrizia Casalbore, Manuela Budoni, Valentina Sposato, Luigi Aloe · 2008 · Neurological Research
  83. Rewiring brain circuits to block cataplexy in murine models of narcolepsy
    Meng Liu, Carlos Blanco‐Centurion, Priyattam J. Shiromani · 2017 · Current Opinion in Neurobiology
  84. Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathway
    Justin B. Davis, Valerie S. Calvert, Steven Roberts, Sabrina Bracero, Emanuel Petricoin, Robin D. Couch · 2018 · Heliyon
  85. Basic Concepts in Viral Vector-Mediated Gene Therapy
    Matthew J. Benskey, Ivette M. Sandoval, Kathryn Miller, Rhyomi C. Sellnow, Aysegul O. Gezer, Nathan C. Kuhn, Roslyn Vashon, Fredric P. Manfredsson · 2019 · Methods in molecular biology
  86. Gene therapy for GM1 gangliosidosis: challenges of translational medicine.
    Carl Hayward, Hitesh C Patel, Sanjay Manohar, Alexander Richard Lyon · 2015 · PubMed Central
  87. New Neuritogenic Steroidal Saponin fromOphiopogon japonicus(Thunb.) Ker-Gawl
    Yuan Qu, Yang Zhang, Liang PEI, Yan Wang, Lijuan Gao, Qianming Huang, Makoto Ojika, Youji Sakagami, Jianhua Qi · 2011 · Bioscience Biotechnology and Biochemistry
  88. Nanotechnology, Nanostructure, and Nervous System Disorders
    Nancy J. Woolf, Avner Priel, Jack A. Tuszyński · 2009 · Biological and medical physics series
  89. Distinctive effect on nerve growth factor-induced PC12 cell neurite outgrowth by two unique neolignan enantiomers from Illicium merrillianum
    Xin-Hui Tian, Rongcai Yue, Hua‐Wu Zeng, Honglin Li, Lei Shan, Weiwei He, Yun‐Heng Shen, Weidong Zhang · 2015 · Scientific Reports
  90. Concepts in Genetic Medicine
    2007 · Wiley eBooks
  91. Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets
    A. Claudio Cuello · 2007 · Springer eBooks
  92. Improvement in reproductive parameters in hypogonadal female mice by regulated gene replacement therapy in the central nervous system
    K-H Jeong, Joanna C. Bakowska, I O Song, N Fu, Xandra O. Breakefield, Ursula B. Kaiser · 2007 · Gene Therapy
  93. Données fondamentales sur les pathologies amyloïde et Tau dans la maladie d’Alzheimer : quelles perspectives thérapeutiques ?
    Frédéric Checler, Luc Buée · 2009 · Annales Pharmaceutiques Françaises
  94. Bionic Microtubules: Potential Applications to Multiple Neurological and Neuropsychiatric Diseases
    Nancy J. Woolf · 2009 · Journal of Nanoneuroscience
  95. Stem Cells in the Treatment of Stroke
    Klaudia Urbaniak Hunter, Chester K. Yarbrough, Joseph D. Ciacci · 2010 · Advances in experimental medicine and biology
  96. Non-Drug and Non-Invasive Therapeutic Options in Alzheimer’s Disease
    Alina Simona Şovrea, Adina Bianca Boşca, Eleonora Dronca, Anne-Marie Constantin, Andreea Crintea, Rada Teodora Suflețel, Roxana-Adelina Lupean, Paul-Andrei Ștefan, Mădălin Mihai Onofrei, Christoph Tschall et al. · 2025 · Biomedicines
  97. Nerve growth factor: what can surgeons and oncologists learn from a neurological and psychological biomarker?
    Fei Xiong, Ben-li Xiao, Qi Wang, Kun Liu, Hong-Wei Wu, Chao Jing, Kui-nan Tong, Zhongtao Zhang, Wei Guo · 2025 · Molecular Medicine
  98. Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson’s
    Jeyaram Bharathi Jeyabalan, Nagarjuna Palathoti, Muralikrishnan Dhanasekaran, R. Sivasamy, Sivasankaran Ponnusankar, S. P. Dhanabal, Veintramuthu Sankar, Antony Justin · 2023 · Neurological Sciences
  99. P2Y1 receptor in Alzheimer’s disease
    Shan Luo, Yifei Wang, Tatsuhiro Hisatsune · 2024 · Neural Regeneration Research
  100. Gene Therapy Clinical Trials in the Human Brain
    Michael G. Kaplitt · 2009 · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences